| View |
|
DR-XY44191
|
Phytomenadione
|
Phytobas
|
10 mg/mL
|
Solution For Injection (I.V./I.M./S.C.)
|
-
|
Harmann Pharmaceutical Laboratories (Pvt) Ltd.
|
Pakistan
|
Automatic Renewal (Variation: PCPR Conversion) (Correction)
|
18 July 2022
|
13 February 2025
|
| View |
|
DR-XY44192
|
Mupirocin
|
None
|
20 mg/g (1% w/w)
|
Ointment
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
05 August 2020
|
11 February 2025
|
| View |
|
DR-XY44193
|
Quetiapine (As Fumarate)
|
Serendra
|
200 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratores, Inc.
|
Philippines
|
-
|
21 February 2020
|
17 February 2025
|
| View |
|
DR-XY44194
|
Rosuvastatin Calcium
|
Torros
|
20 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories Inc.
|
Philippines
|
-
|
19 February 2020
|
11 February 2025
|
| View |
|
DR-XY44195
|
Rosuvastatin Calcium
|
Torros
|
10 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
19 February 2020
|
11 February 2025
|
| View |
|
DR-XY44197
|
Rosuvastatin Calcium
|
None
|
10 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
28 January 2020
|
12 February 2025
|
| View |
|
DR-XY44198
|
Rosuvastatin Calcium
|
Rosustat
|
10 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal (Reconstruction)
|
06 February 2024
|
23 February 2025
|
| View |
|
DR-XY44199
|
Rosuvastatin Calcium
|
None
|
10 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
28 July 2021
|
23 February 2025
|
| View |
|
DR-XY44202
|
Fluticasone Furoate + Vilanterol (As Trifenatate)
|
Relvar Ellipta
|
100mcg/25mcg (eq. to 92mcg/22 mcg delivered dose
|
Dry Powder For Inhalation
|
-
|
Glaxo Operations UK Ltd.
|
United Kingdom
|
Initial [from Monitored Release]
|
17 March 2022
|
13 February 2025
|
| View |
|
DR-XY44203
|
Fluticasone Furoate + Vilanterol (as trifenatate)
|
Relvar Ellipta
|
200 mcg/25 mcg (equivalent to 184 mcg/22 mcg
delivered dose)
|
Dry Powder For Inhalation
|
-
|
Glaxo Operations UK Ltd.
|
United Kingdom
|
Initial [from Monitored Release] Reconstruction
|
06 June 2022
|
13 February 2025
|
| View |
|
DR-XY44206
|
Valsartan
|
Arovan-80
|
80 mg
|
Capsule
|
-
|
Aristopharma Ltd.
|
Bangladesh
|
-
|
26 October 2020
|
25 February 2025
|
| View |
|
DR-XY44207
|
Diclofenac Sodium
|
Catafen
|
50mg
|
Suppository
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Bliss GVS Pharma Ltd.
|
India
|
Renewal
|
04 August 2024
|
13 February 2030
|
| View |
|
DR-XY44208
|
Pantoprazole (As Sodium Sesquihydrate)
|
None
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 February 2020
|
17 February 2025
|
| View |
|
DR-XY44209
|
Amoxicillin (As Trihydrate) + Sulbactam (As Pivoxil)
|
Moxitam
|
250mg/ 250mg
|
Film coated tablet
|
-
|
Zhuhai United Laboratories (Zhongshan) Co., Ltd.
|
China
|
-
|
02 January 2020
|
23 January 2025
|
| View |
|
DR-XY44210
|
Hydralazine Hydrochloride
|
Aprezobas
|
20 mg/mL
|
Solution For Injection (I.M./I.V.)
|
-
|
Friends Pharma (Pvt) Ltd.
|
Pakistan
|
-
|
17 April 2020
|
17 February 2025
|
| View |
|
DR-XY44212
|
Midazolam Hydrochloride
|
Dormid
|
1mg/mL(5mg/5mL)
|
Solution for Injection (IM/IV)
|
-
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
-
|
04 March 2021
|
15 February 2026
|
| View |
|
DR-XY44213
|
Midazolam Hydrochloride
|
Dormid
|
5mg/mL (15mg/3mL)
|
Solution for Injection (IM/IV)
|
-
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
-
|
10 March 2021
|
15 February 2026
|
| View |
|
DR-XY44215
|
Simvastatin
|
Lipivast
|
20mg
|
Film Coated tablet
|
-
|
Celogen Pharma Pvt. Ltd.
|
India
|
-
|
27 December 2019
|
24 February 2025
|
| View |
|
DR-XY44216
|
Sodium Chloride
|
None
|
0.9%w/v
|
Solution for Intravenous Infusion
|
-
|
Fresenius Kabi Deutschland GmbH
|
Germany
|
-
|
20 January 2021
|
23 February 2025
|
| View |
|
DR-XY44217
|
Meropenem (as trihydrate)
|
Meropevex
|
1 g
|
Powder For Injection (IV)
|
Antibacterial (Carbapenem)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
14 February 2022
|
18 February 2025
|